Pharmacokinetics of a continuous rate infusion of ceftiofur sodium in normal foals.

The research article focuses on a study that investigated the effectiveness of continuous dosage of Ceftiofur Sodium (a type of antibiotic) in normal foals (baby horses) less than a week old.

Background

• Systemic bacterial infection is a significant cause of mortality in young horses, and the antibiotic Ceftiofur Sodium (CS) is known for its efficacy against many such infections.
• CS is often adopted in a Continuous Rate Infusion (CRI), which ensures sustained levels of the drug in the system over time, for better efficacy.
• This particular study focuses on determining the pharmacokinetics—the bodily absorption, distribution, and elimination of the drug—of CS when administered as a CRI to normal foals aged under 7 days.

Study Method

• Six healthy baby horses were used in the study, kept in individual stalls, and allowed to feed every 2 hours.
• They were administered CS using an intravenous catheter, and the dose and rate of infusion were calculated to achieve and maintain a desired steady-state concentration of the drug.
• Blood samples were collected at regular intervals, both during the infusion and after discontinuation, for detailed analysis. Samples from the infusion solutions were also collected for checking the consistency of the drug.

Significance

• This study is crucial in understanding how CS works when administered as a CRI in infants horses, and helps in formulating effective treatment plans for systemic bacterial infections in equine neonates.
• It can also guide veterinarians to achieve optimal results with CS by maintaining the desired concentration of the drug in the foal’s bodies, taking cognizance of factors like the volume of distribution of the drug and its clearance rate.